KUKJEON PHARMACEUTICAL Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	135,077	136,468	121,998	103,711	85,354
Other Revenue	-0	-0	-	-	-0
Revenue	135,077	136,468	121,998	103,711	85,354
Revenue Growth (YoY)	1.35%	11.86%	17.63%	21.51%	-
Cost of Revenue	116,214	114,594	96,721	84,195	67,409
Gross Profit	18,863	21,874	25,277	19,515	17,946
Selling, General & Admin	14,907	15,327	12,817	11,451	8,699
Research & Development	4,061	4,684	4,821	3,981	2,651
Operating Expenses	21,200	21,507	18,768	16,027	11,836
Operating Income	-2,337	366.71	6,509	3,488	6,109
Interest Expense	-7,136	-8,220	-5,735	-1,802	-284.47
Interest & Investment Income	300.38	878.98	1,591	1,037	208.91
Earnings From Equity Investments	-146.08	-57.48	1.15	301.09	-
Currency Exchange Gain (Loss)	276.31	-1,655	-253.67	-1,215	-869.65
Other Non Operating Income (Expenses)	8,982	10,498	-391.28	9,279	196.4
EBT Excluding Unusual Items	-60.7	1,811	1,722	11,089	5,360
Gain (Loss) on Sale of Investments	2,313	1,831	16.28	67.84	-275.98
Gain (Loss) on Sale of Assets	-49.07	-57.43	-	-69.18	-0
Other Unusual Items	-3,637	-2,706	-	-	-
Pretax Income	-1,433	879.32	1,738	11,088	5,084
Income Tax Expense	303.35	341.65	-2,954	2,210	1,046
Earnings From Continuing Operations	-1,737	537.67	4,692	8,877	4,038
Minority Interest in Earnings	960.65	1,199	132	70.7	-
Net Income	-776.19	1,736	4,824	8,948	4,038
Net Income to Common	-776.19	1,736	4,824	8,948	4,038
Net Income Growth	-	-64.01%	-46.09%	121.59%	-
Shares Outstanding (Basic)	49	49	49	49	44
Shares Outstanding (Diluted)	49	49	49	51	44
Shares Change (YoY)	-9.13%	-	-4.23%	16.16%	-
EPS (Basic)	-15.73	35.38	98.31	182.35	91.54
EPS (Diluted)	-15.73	35.38	98.31	11.35	91.00
EPS Growth	-	-64.01%	766.11%	-87.53%	-
Free Cash Flow	1,053	2,169	-44,269	-29,304	-7,367
Free Cash Flow Per Share	21.33	44.20	-902.17	-571.94	-167.01
Dividend Per Share	10.000	10.000	-	-	-
Gross Margin	13.96%	16.03%	20.72%	18.82%	21.02%
Operating Margin	-1.73%	0.27%	5.33%	3.36%	7.16%
Profit Margin	-0.57%	1.27%	3.95%	8.63%	4.73%
Free Cash Flow Margin	0.78%	1.59%	-36.29%	-28.26%	-8.63%
EBITDA	2,913	5,472	9,643	4,932	7,215
EBITDA Margin	2.16%	4.01%	7.90%	4.75%	8.45%
D&A For EBITDA	5,250	5,105	3,134	1,444	1,106
EBIT	-2,337	366.71	6,509	3,488	6,109
EBIT Margin	-1.73%	0.27%	5.33%	3.36%	7.16%
Effective Tax Rate	-	38.85%	-	19.94%	20.58%

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.